← FDA Drug Approvals (Drugs@FDA)

ANDA213205

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2023-05-26

Drug application

FDA Application #

ANDA213205

Application type

Abbreviated New Drug Application (Generic)

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

FRESENIUS KABI USA

First approval

2023-05-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown